2020 American Transplant Congress
Center Effects on Post-Transplant Outcomes in Liver Transplantation for Hilar Cholangiocarcinoma
*Purpose: Based on favorable outcomes reported by experienced centers, perihilar cholangiocarcinoma (Ph-CCA) has become an accepted indication for liver transplantation (LT). In the United States,…2020 American Transplant Congress
Long-Term Liver Transplant Outcomes: A Single Center Cohort Study
Mayo Clinic Florida, Jacksonville, FL
*Purpose: This single center study reviews long-term outcomes of liver transplantation identifying morbidity differences between post-transplant liver patients surviving greater than five years versus those…2020 American Transplant Congress
Performance of the Retreat Score in Predicting Post-Transplant Hepatocellular Carcinoma Recurrence at a Large Academic Center
Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: Post-transplant hepatocellular carcinoma recurrence (R-HCC) results in poor outcomes. The RETREAT score was recently derived to predict HCC recurrence, incorporating pre-transplant alpha fetoprotein and…2020 American Transplant Congress
Recurrence of IgA Nephropathy after Kidney Transplantation – Tango Multicenter Study
*Purpose: In patients with IgA nephropathy as the cause of ESKD, IgA deposits can recur in the transplanted kidney. However,the incidence and clinical impact of…2020 American Transplant Congress
Multiple Downstaging Episodes for Hepatocellular Carcinoma Prior to Liver Transplant Increases Risk of Post-Transplant HCC Recurrence
Henry Ford Hospital, Detroit, MI
*Purpose: Early-stage Hepatocellular Carcinoma (HCC) is best managed with liver transplantation (LT). Several studies have shown that patients meeting Milan or successfully downstaged to meet…2020 American Transplant Congress
Recurrence of Igg3Lambda Restricted Cryoglobulinemic Glomerulonephritis in a Renal Allograft: Resolution after Daratumumab Treatment
Cedars Sinai Medical Ctr, Los Angeles, CA
*Purpose: C3GN encompasses a group of renal diseases often associated with paraproteinemias. Recurrence in renal allografts is reported. Currently, there are no effective or curative…2020 American Transplant Congress
Hepatocellular Carcinoma Recurrence after Severe Acute Cellular Rejection
1Columbia University Irving Medical Center, New York, NY, 2Weill Cornell Medicine, New York, NY
*Purpose: The interplay between acute cellular rejection (ACR), immunosuppression and hepatocellular carcinoma (HCC) recurrence in patients who underwent liver transplantation (LT) for HCC is still…2020 American Transplant Congress
A Long-Term Follow-Up Study of High-Dose Intravenous Cyclosporine Combined Plasma Exchange in the Treatment of FSGS Recurrence after Renal Transplantation – A Single Center Clinical Experience
*Purpose: There was still lack of effective treatment for focal segmental glomerulosclerosis(FSGS)recurrence after renal transplantation. The purpose of this study was to explore the risk…2020 American Transplant Congress
Beyond Milan- Not Paying the Price
Columbia University, New york, NY
*Purpose: Early stage hepatocellular carcinoma (HCC) patients meeting the Milan Criteria have access to Orthotopic Liver Transplantation (OLT) as a curative treatment. However, a substantial…2020 American Transplant Congress
Imaging Features and Diagnostic Accuracy of MRI in Combined Hepatocholangiocarcinoma
*Purpose: Combined hepatocholangiocarcinomas (HCC-CCA) are rare tumors with both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) differentiations. They are usually associated with a worse prognosis after…
American Transplant Congress abstracts